A comprehensive view of Vaccination/Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually
Published:
August 17, 2022
by Xinhua News Agency
|
Merck collaborating with biotechnology firm Orna Therapeutics to develop, commercialize infectious disease, oncology vaccines and therapeutics based on Orna’s oRNA technology; Merck paid Orna US$150.0M upfront as part of deal
Published:
August 17, 2022
by Business Wire
|
Novavax seeks FDA approval for its protein-based NVX-CoV2373 COVID-19 vaccine for use as a booster dose in adults; the FDA approved the vaccine for emergency use in the US in July
Published:
August 17, 2022
by SeeNews Pharmaceuticals
|
British regulator 1st to OK Moderna's updated COVID booster
Published:
August 16, 2022
by Associated Press
|
European Medicine Agency starts rolling review of Pfizer and Biontech’s BA.4/5 Omicron-adapted COVID-19 vaccine candidate; the companies are manufacturing two versions of the vaccine based on different Omicron subvariants
Published:
August 15, 2022
by SeeNews Pharmaceuticals
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count